2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理

2017-12-18 欧洲骨髓瘤网络 Leukemia. 2017 Dec 18.

2017年12月，欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识。在过去的几年里，一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者。本文主要总结了这些新药相关的不良事件，并针对这些不良事件的的预防和管理提供指导。

中文标题：

英文标题：

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

发布机构：

欧洲骨髓瘤网络

发布日期：

2017-12-18

简要介绍：

2017年12月，欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识。在过去的几年里，一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者。本文主要总结了这些新药相关的不良事件，并针对这些不良事件的的预防和管理提供指导。

拓展指南：与多发性骨髓瘤相关指南：

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=31f191c00153a10d, title=2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理, enTitle=Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network., guiderFrom=Leukemia. 2017 Dec 18., authorId=null, author=, summary=2017年12月，欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识。在过去的几年里，一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者。本文主要总结了这些新药相关的不良事件，并针对这些不良事件的的预防和管理提供指导。 , cover=, journalId=null, articlesId=null, associationId=1564, associationName=欧洲骨髓瘤网络, associationIntro=, copyright=0, guiderPublishedTime=Mon Dec 18 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年12月，欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识。在过去的几年里，一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者。本文主要总结了这些新药相关的不良事件，并针对这些不良事件的的预防和管理提供指导。 拓展指南：与多发性骨髓瘤相关指南： <UL> <LI><A title=2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=9b91f1c00152ae45">2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读</A> <LI><A title=《中国多发性骨髓瘤诊治指南(2017年修订)》复发/难治骨髓瘤治疗部分的解读 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=dc1db1c00152a016">《中国多发性骨髓瘤诊治指南(2017年修订)》复发/难治骨髓瘤治疗部分的解读</A> <LI><A title=《中国多发性骨髓瘤诊治指南(2017年修订)》初始治疗部分的解读 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=5c5d21c0015231cb">《中国多发性骨髓瘤诊治指南(2017年修订)》初始治疗部分的解读</A> <LI><A title=多发性骨髓瘤肾损伤诊治专家共识 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=70ae01c001523032">多发性骨髓瘤肾损伤诊治专家共识</A> <LI><A title=中国多发性骨髓瘤诊治指南(2017年修订) target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=5602a1c001521a58">中国多发性骨髓瘤诊治指南(2017年修订)</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E5%A4%9A%E5%8F%91%E6%80%A7%E9%AA%A8%E9%AB%93%E7%98%A4">有关多发性骨髓瘤更多指南</A></LI></UL>, tagList=[TagDto(tagId=321, tagName=多发性骨髓瘤), TagDto(tagId=598, tagName=新药), TagDto(tagId=2866, tagName=不良事件)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5779, appHits=191, showAppHits=0, pcHits=3871, showPcHits=2335, likes=122, shares=7, comments=5, approvalStatus=1, publishedTime=Wed Dec 20 23:18:21 CST 2017, publishedTimeString=2017-12-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 20 23:18:21 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:21:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理)])

2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=271878, encodeId=b51b2e1878eb, content=2017年12月.欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识.在过去的几年里.一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者.本文主要总结了这些新药相关的不良事件.并针对这些不良事件的的预防和管理提供指导. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Dec 23 16:53:01 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271876, encodeId=91e22e1876f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Sat Dec 23 16:44:41 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271085, encodeId=d8ad2e10854b, content=谢谢分享.阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Dec 21 06:55:49 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271065, encodeId=3d552e106505, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Dec 21 05:26:21 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
2017-12-23 有备才能无患

2017年12月.欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识.在过去的几年里.一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者.本文主要总结了这些新药相关的不良事件.并针对这些不良事件的的预防和管理提供指导. ?

115 0
[GetPortalCommentsPageByObjectIdResponse(id=271878, encodeId=b51b2e1878eb, content=2017年12月.欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识.在过去的几年里.一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者.本文主要总结了这些新药相关的不良事件.并针对这些不良事件的的预防和管理提供指导. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Dec 23 16:53:01 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271876, encodeId=91e22e1876f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Sat Dec 23 16:44:41 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271085, encodeId=d8ad2e10854b, content=谢谢分享.阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Dec 21 06:55:49 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271065, encodeId=3d552e106505, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Dec 21 05:26:21 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
2017-12-23 兰亭序123

学习了

146 0
[GetPortalCommentsPageByObjectIdResponse(id=271878, encodeId=b51b2e1878eb, content=2017年12月.欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识.在过去的几年里.一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者.本文主要总结了这些新药相关的不良事件.并针对这些不良事件的的预防和管理提供指导. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Dec 23 16:53:01 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271876, encodeId=91e22e1876f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Sat Dec 23 16:44:41 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271085, encodeId=d8ad2e10854b, content=谢谢分享.阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Dec 21 06:55:49 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271065, encodeId=3d552e106505, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Dec 21 05:26:21 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
2017-12-21 刘煜

谢谢分享.阅读

157 0
[GetPortalCommentsPageByObjectIdResponse(id=271878, encodeId=b51b2e1878eb, content=2017年12月.欧洲骨髓瘤网络(EMN)发布了多发性骨髓瘤新药不良事件的预防和管理共识.在过去的几年里.一些可以明显改善治疗结局的新药已经被用于治疗多发性骨髓瘤患者.本文主要总结了这些新药相关的不良事件.并针对这些不良事件的的预防和管理提供指导. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Dec 23 16:53:01 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271876, encodeId=91e22e1876f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Sat Dec 23 16:44:41 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271085, encodeId=d8ad2e10854b, content=谢谢分享.阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Dec 21 06:55:49 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271065, encodeId=3d552e106505, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Dec 21 05:26:21 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
2017-12-21 yjs木玉

好好好好好好好好

138 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

血液科指南

2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理

相关指南

科室

工具

服务